This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Hsu, S.-H. Articles by Li, H. Search for Related Content PubMed PubMed Citation Articles by Hsu, S.-H. Articles by Li, H.

bHLH-zip Transcription Factor Spz1 Mediates Mitogen-Activated Protein Kinase Cell Proliferation, Transformation, and Tumorigenesis

¹ Institute of Molecular Biology, Academia Sinica; ² Department of Life Science, National Taiwan Normal University; ³ Department of Pathology, National Taiwan University Hospital; and ⁴ Institute of Biochemistry, National Yang-Ming University, Taipei, Taiwan

Requests for reprints: Hung Li, Institute of Molecular Biology, Academia Sinica, Taipei 115, Taiwan. Phone: 886-2-27880460; Fax: 886-2-27826085; E-mail: hungli{at}ccvax.sinica.edu.tw.

BHLH-zip proteins usually play important regulatory roles in cell growth and differentiation. In this study, we show that Spz1, a bHLH-zip transcription factor, acts downstream of mitogen-activated protein kinase (MAPK, extracellular signal-regulated kinase 1/2) to up-regulate cell proliferation and tumorigenesis. In addition, through an interaction with proliferating cell nuclear antigen (PCNA) promoter, Spz1 induced cell proliferation concomitant with an increase in PCNA gene expression. Spz1-transfected cells formed colony foci on soft agar and developed fibrosarcoma tumors in nude mice. MAPK directly interacted and phosphorylated Spz1 protein, which increased PCNA transcription and cell tumorigenic activities. Reduction of endogenous Spz1 expression via RNA interference decreased cell proliferation in p19 embryonic carcinoma cells. High levels of Spz1 expression were detected in murine tumor cell lines and tumor samples of both human and Spz1 transgenic mice. Thus, Spz1 may act as a proto-oncogene, participating in the MAPK signal pathway, and be a potential therapeutic target in the treatment of Ras-induced tumors.